Luminex Q2 Revenues Triple: New Universal Microarray Program Announced | GenomeWeb

NEW YORK, July 26 - Due to strong sales of its Luminex 100 systems and continuing collaborations, Luminex reported second-quarter 2001 revenues of $4.7 million, more than triple the $1.4 million in revenues the company reported for the second quarter of 2000, the company said Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.